Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000093751-26-000024·BIOCRYST PHARMACEUTICALS INC
Schedule 13G ownership disclosure
BIOCRYST PHARMACEUTICALS INC
COMMON STOCK · CUSIP: 09058V103
Event date: 2025-12-31
- Filing-level shares
- 11,073,211.00
- Percent of class
- 5.3%
- STATE STREET CORPORATION
Shares: 11,073,211.00 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-26-000024
- Form type
- SCHEDULE 13G
- Filer
- BIOCRYST PHARMACEUTICALS INC
- CIK
- CIK 882796
- Filed
- Feb 09, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership